NO170418C - Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider - Google Patents

Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider

Info

Publication number
NO170418C
NO170418C NO89894350A NO894350A NO170418C NO 170418 C NO170418 C NO 170418C NO 89894350 A NO89894350 A NO 89894350A NO 894350 A NO894350 A NO 894350A NO 170418 C NO170418 C NO 170418C
Authority
NO
Norway
Prior art keywords
pyrrolophenotiazine
pyrrolokinolin
carboxamids
preparation
analogy procedure
Prior art date
Application number
NO89894350A
Other languages
English (en)
Norwegian (no)
Other versions
NO170418B (no
NO894350D0 (no
NO894350L (no
Inventor
Banavara Lakshmana Mylari
Joseph George Lombardino
James Michael Mcmanus
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO894350D0 publication Critical patent/NO894350D0/no
Publication of NO894350L publication Critical patent/NO894350L/no
Publication of NO170418B publication Critical patent/NO170418B/no
Publication of NO170418C publication Critical patent/NO170418C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO89894350A 1988-03-11 1989-11-01 Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider NO170418C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/000781 WO1989008654A1 (en) 1988-03-11 1988-03-11 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Publications (4)

Publication Number Publication Date
NO894350D0 NO894350D0 (no) 1989-11-01
NO894350L NO894350L (no) 1989-11-01
NO170418B NO170418B (no) 1992-07-06
NO170418C true NO170418C (no) 1992-10-14

Family

ID=22208596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894350A NO170418C (no) 1988-03-11 1989-11-01 Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider

Country Status (15)

Country Link
EP (1) EP0332364A3 (ja)
JP (1) JPH0676408B2 (ja)
KR (1) KR910002565B1 (ja)
AU (1) AU605410B2 (ja)
CA (1) CA1335592C (ja)
DK (1) DK169723B1 (ja)
FI (1) FI96315C (ja)
HU (1) HU201757B (ja)
IL (1) IL89480A (ja)
MY (1) MY104955A (ja)
NO (1) NO170418C (ja)
NZ (1) NZ228299A (ja)
PT (1) PT89954B (ja)
WO (1) WO1989008654A1 (ja)
ZA (1) ZA891800B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
JPH06279444A (ja) * 1993-03-31 1994-10-04 Tokyo Tanabe Co Ltd インドリジン誘導体
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
WO1999043670A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US7696192B2 (en) * 2004-09-09 2010-04-13 Merck Sharp & Dohme Corp. Tricyclic anilide spirolactam CGRP receptor antagonists
ATE518852T1 (de) * 2004-09-13 2011-08-15 Merck Sharp & Dohme Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten
US7741317B2 (en) * 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CN108853102B (zh) * 2017-05-15 2021-04-09 北京大学 作用于Dectin-1的稠合吖啶衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法

Also Published As

Publication number Publication date
KR910002565B1 (ko) 1991-04-26
AU605410B2 (en) 1991-01-10
EP0332364A3 (en) 1991-04-03
FI96315C (fi) 1996-06-10
HU885829D0 (en) 1990-02-28
PT89954A (pt) 1989-11-10
JPH0676408B2 (ja) 1994-09-28
EP0332364A2 (en) 1989-09-13
DK169723B1 (da) 1995-01-23
NZ228299A (en) 1990-09-26
IL89480A0 (en) 1989-09-10
ZA891800B (en) 1990-10-31
NO170418B (no) 1992-07-06
IL89480A (en) 1994-04-12
FI895333A0 (fi) 1989-11-09
CA1335592C (en) 1995-05-16
JPH01275580A (ja) 1989-11-06
HU201757B (en) 1990-12-28
DK116689A (da) 1989-09-12
DK116689D0 (da) 1989-03-10
KR890014545A (ko) 1989-10-24
WO1989008654A1 (en) 1989-09-21
MY104955A (en) 1994-07-30
FI96315B (fi) 1996-02-29
PT89954B (pt) 1994-05-31
NO894350D0 (no) 1989-11-01
NO894350L (no) 1989-11-01
AU3120489A (en) 1989-09-14

Similar Documents

Publication Publication Date Title
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
ES2017015B3 (es) Procedimiento de preparacion de disulfuros y polisulfuros organicos
NO171167C (no) Analogifremgangsmaate ved fremstilling av cytidin-derivater
NO171979C (no) Analogifremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater
NO170216C (no) Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO177496C (no) Fremgangsmåte ved fremstilling av mono-N-alkylerte polyazamakrocykler
NO892068L (no) Fremgangsmaate ved fremstilling av naftatiozepinoner.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO883392L (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO170418C (no) Analogifremgangsmaate ved fremstilling av pyrrolokinolin- og pyrrolofenotiazinkarboksamider
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO167284C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater.
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO894185L (no) Fremgangsmaate for fremstilling av 1-buten- og/eller heksener.
NO172844C (no) Fremgangsmaate for fremstilling av syntesegass
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO892432D0 (no) Fremgangsmaate for fremstilling av kondenserte diazepinoner
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander